These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 10530823)

  • 21. The neuroprotective effects of orthosteric agonists of group II and III mGluRs in primary neuronal cell cultures are dependent on developmental stage.
    Jantas D; Gręda A; Gołda S; Korostyński M; Lasoń W
    Neuropharmacology; 2016 Dec; 111():195-211. PubMed ID: 27600687
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Protection with metabotropic glutamate 1 receptor antagonists in models of ischemic neuronal death: time-course and mechanisms.
    Pellegrini-Giampietro DE; Peruginelli F; Meli E; Cozzi A; Albani-Torregrossa S; Pellicciari R; Moroni F
    Neuropharmacology; 1999 Oct; 38(10):1607-19. PubMed ID: 10530822
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Enhancement of NMDA responses by group I metabotropic glutamate receptor activation in striatal neurones.
    Pisani A; Calabresi P; Centonze D; Bernardi G
    Br J Pharmacol; 1997 Mar; 120(6):1007-14. PubMed ID: 9134210
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Synthesis and biology of the conformationally restricted ACPD analogue, 2-aminobicyclo[2.1.1]hexane-2,5-dicarboxylic acid-I, a potent mGluR agonist.
    Kozikowski AP; Steensma D; Araldi GL; Tückmantel W; Wang S; Pshenichkin S; Surina E; Wroblewski JT
    J Med Chem; 1998 May; 41(10):1641-50. PubMed ID: 9572889
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Activation of class II or III metabotropic glutamate receptors protects cultured cortical neurons against excitotoxic degeneration.
    Bruno V; Battaglia G; Copani A; Giffard RG; Raciti G; Raffaele R; Shinozaki H; Nicoletti F
    Eur J Neurosci; 1995 Sep; 7(9):1906-13. PubMed ID: 8528465
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Distinct properties of presynaptic group II and III metabotropic glutamate receptor-mediated inhibition of perforant pathway-CA1 EPSCs.
    Capogna M
    Eur J Neurosci; 2004 May; 19(10):2847-58. PubMed ID: 15147318
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Selective mGluR5 antagonists MPEP and SIB-1893 decrease NMDA or glutamate-mediated neuronal toxicity through actions that reflect NMDA receptor antagonism.
    O'Leary DM; Movsesyan V; Vicini S; Faden AI
    Br J Pharmacol; 2000 Dec; 131(7):1429-37. PubMed ID: 11090117
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Activation of metabotropic glutamate receptors coupled to inositol phospholipid hydrolysis amplifies NMDA-induced neuronal degeneration in cultured cortical cells.
    Bruno V; Copani A; Knöpfel T; Kuhn R; Casabona G; Dell'Albani P; Condorelli DF; Nicoletti F
    Neuropharmacology; 1995 Aug; 34(8):1089-98. PubMed ID: 8532158
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Selective agonist of group II glutamate metabotropic receptors, LY354740, inhibits tolerance to analgesic effects of morphine in mice.
    Popik P; Kozela E; Pilc A
    Br J Pharmacol; 2000 Jul; 130(6):1425-31. PubMed ID: 10903986
    [TBL] [Abstract][Full Text] [Related]  

  • 30. LY354740, a group II metabotropic glutamate receptor agonist with potential antiparkinsonian properties in rats.
    Konieczny J; Ossowska K; Wolfarth S; Pilc A
    Naunyn Schmiedebergs Arch Pharmacol; 1998 Oct; 358(4):500-2. PubMed ID: 9826074
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pharmacological and pharmacokinetic properties of a structurally novel, potent, and selective metabotropic glutamate 2/3 receptor agonist: in vitro characterization of agonist (-)-(1R,4S,5S,6S)-4-amino-2-sulfonylbicyclo[3.1.0]-hexane-4,6-dicarboxylic acid (LY404039).
    Rorick-Kehn LM; Johnson BG; Burkey JL; Wright RA; Calligaro DO; Marek GJ; Nisenbaum ES; Catlow JT; Kingston AE; Giera DD; Herin MF; Monn JA; McKinzie DL; Schoepp DD
    J Pharmacol Exp Ther; 2007 Apr; 321(1):308-17. PubMed ID: 17204749
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Neuroprotection by metabotropic glutamate receptor glutamate receptor agonists: LY354740, LY379268 and LY389795.
    Kingston AE; O'Neill MJ; Lam A; Bales KR; Monn JA; Schoepp DD
    Eur J Pharmacol; 1999 Jul; 377(2-3):155-65. PubMed ID: 10456425
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Blockade of glutamate transporters leads to potentiation of NMDA receptor current in layer V pyramidal neurons of the rat prefrontal cortex via group II metabotropic glutamate receptor activation.
    Oliveira JF; Krügel U; Köles L; Illes P; Wirkner K
    Neuropharmacology; 2008 Sep; 55(4):447-53. PubMed ID: 18680754
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cocaine and kindling alter the sensitivity of group II and III metabotropic glutamate receptors in the central amygdala.
    Neugebauer V; Zinebi F; Russell R; Gallagher JP; Shinnick-Gallagher P
    J Neurophysiol; 2000 Aug; 84(2):759-70. PubMed ID: 10938303
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Activation of mGlu1 but not mGlu5 metabotropic glutamate receptors contributes to postischemic neuronal injury in vitro and in vivo.
    Meli E; Picca R; Attucci S; Cozzi A; Peruginelli F; Moroni F; Pellegrini-Giampietro DE
    Pharmacol Biochem Behav; 2002 Sep; 73(2):439-46. PubMed ID: 12117599
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Group II metabotropic glutamate receptor activation attenuates traumatic neuronal injury and improves neurological recovery after traumatic brain injury.
    Allen JW; Ivanova SA; Fan L; Espey MG; Basile AS; Faden AI
    J Pharmacol Exp Ther; 1999 Jul; 290(1):112-20. PubMed ID: 10381766
    [TBL] [Abstract][Full Text] [Related]  

  • 37. 1-amino-APDC, a partial agonist of group II metabotropic glutamate receptors with neuroprotective properties.
    Kozikowski AP; Araldi GL; Tückmantel W; Pshenichkin S; Surina E; Wroblewski JT
    Bioorg Med Chem Lett; 1999 Jun; 9(12):1721-6. PubMed ID: 10397508
    [TBL] [Abstract][Full Text] [Related]  

  • 38. In vivo inhibition of veratridine-evoked release of striatal excitatory amino acids by the group II metabotropic glutamate receptor agonist LY354740 in rats.
    Battaglia G; Monn JA; Schoepp DD
    Neurosci Lett; 1997 Jul; 229(3):161-4. PubMed ID: 9237483
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Potent, stereoselective, and brain region selective modulation of second messengers in the rat brain by (+)LY354740, a novel group II metabotropic glutamate receptor agonist.
    Schoepp DD; Johnson BG; Wright RA; Salhoff CR; Monn JA
    Naunyn Schmiedebergs Arch Pharmacol; 1998 Aug; 358(2):175-80. PubMed ID: 9750002
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Differential changes of group II and group III mGluR function in central amygdala neurons in a model of arthritic pain.
    Li W; Neugebauer V
    J Neurophysiol; 2006 Oct; 96(4):1803-15. PubMed ID: 16760343
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.